- ￥2260
- LSM Bio
- 进口
- PAab09268
- 2025年07月10日
- ELISA,WB,IP
- E. coli - derived recombinant protein
- Human, Mouse
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
plasminogen activator, urokinase receptor
- 亚型：
IgG
- 形态：
liquid
- 保存条件：
负20摄氏度
- 克隆性：
Polyclonal antibody
- 标记物：
Non-conjugated
- 适应物种：
Human, Mouse
- 保质期：
6个月
- 抗原来源：
Rabbit
- 目录编号：
Q9BZJ3
- 级别：
纯化级别
- 库存：
50
- 供应商：
LSM bio
- 宿主：
E. coli - derived recombinant protein
- 应用范围：
ELISA,WB,IP
- 浓度：
≥95% as determined by SDS-PAGE
- 靶点：
plasminogen activator, urokinase receptor
- 抗体英文名：
anti-uPAR antibody,uPAR antibody
- 抗体名：
anti-uPAR 抗体,uPAR 抗体
- 规格：
100μl
uPAR抗体| uPAR antibody
货号 PAab09268
蛋白别名 CD87 antibody, MO3 antibody, PLAUR antibody, U PAR antibody, UPAR antibody, URKR
蛋白介绍
Urokinase plasminogen activator surface receptor (uPAR, also known as PLAUR or CD87) is a 45-65 kDa, highly glycosylated, GPI-anchored membrane protein. It contains three homologous domains (D1-D3) of which the N-terminal one (D1) represents the uPA-binding domain. After binding to uPAR, urokinase plasminogen activator (uPA) cleaves plasminogen, generating the active protease plasmin which is involved in a wide variety of physiologic and pathologic processes. In addition to regulating proteolysis, uPAR has important function in cell adhesion, migration and proliferation. Studies reveal that uPAR expression is elevated during inflammation and tissue remodelling and in many human cancers, in which it frequently indicates poor prognosis. (PMID 20027185; 12461559)
产品描述
anti-uPAR antibody is a Rabbit Polyclonal antibody againstuPAR..
建议稀释比例
WB : 1:200-1:2000;IP：1:200-1:1000
IHC
Western blot
RAW264.7 cells were subjected to SDS PAGE followed by western blot with PAab09268(uPAR, PLAUR antibody) at dilution of 1:500(本抗体仅供体外科研用途，不可用于临床诊断!) "">
""> ""> ""> ""> ""> "">风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验人尿激酶型纤溶酶原激活物受体（PLAUR/uPAR) 酶联免疫分析（ ELISA ） 试剂盒使用说明书 本试剂仅供研究使用 目的：本试剂盒用于测定人血清，细胞上清及相关液体样本中尿激酶型纤溶酶原激活物受体（PLAUR/uPAR) 的 含量。 实验原理： 本试剂盒应用双抗体夹心法测定标本中 人尿激酶型纤溶酶原激活物受体（ PLAUR/uPAR) 水平。用纯化的 人尿激酶型纤溶
is almost catalytic when compared to antisense silencing. Of these targets, the uPAR-uPA system and MMPs holds great promise. Targeting uPA/uPAR may provide additive or synergistic treatment benefits if used in combination with conventional therapeutics
Dissecting the Urokinase Activation Pathway Using Urokinase-Activated Anthrax Toxin
by western blotting analysis of cell lysates in vitro, or cell or animal death in vivo. Here, we describe the use of PrAg-U2 as a molecular reporter tool to test the controversial question of what components are required for uPAR-mediated cell surface pro-uPA
技术资料暂无技术资料 索取技术资料
